Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel H Giles

Showing results (31-40 of 129) with videos related to

Pageof 13
Sort By:
Cytoskeleton (Hoboken, N.J.)|January 20, 2011
A role for central spindle proteins in cilia structure and functionKatherine R Smith, Esther K Kieserman, Peggy I Wang, et al.
FEBS Letters|September 11, 2007
The von Hippel-Lindau tumour suppressor interacts with microtubules through kinesin-2Martijn P Lolkema, Dorus A Mans, Cristel M Snijckers, et al.
Cilia|February 2, 2013
Reduced cilia frequencies in human renal cell carcinomas versus neighboring parenchymal tissueSander G Basten, Sven Willekers, Joost Sp Vermaat, et al.
Disease Models & Mechanisms|March 26, 2010
von Hippel-Lindau tumor suppressor mutants faithfully model pathological hypoxia-driven angiogenesis and vascular retinopathies in zebrafishEllen van Rooijen, Emile E Voest, Ive Logister, et al.
Nephron|December 23, 2014
Functional models for congenital anomalies of the kidney and urinary tractGlenn van de Hoek, Nayia Nicolaou, Rachel H Giles, et al.
European Journal of Medical Genetics|July 15, 2018
Characterization of VHL promoter variants in patients suspected of Von Hippel-Lindau diseaseSaleh Albanyan, Rachel H Giles, Enric Mocholi Gimeno, et al.
Blood|March 24, 2009
Zebrafish mutants in the von Hippel-Lindau tumor suppressor display a hypoxic response and recapitulate key aspects of Chuvash polycythemiaEllen van Rooijen, Emile E Voest, Ive Logister, et al.
European Urology Focus|October 2, 2021
Providing a Framework for Meaningful Patient Involvement in Clinical Practice Guideline Development and ImplementationJosefine Björkqvist, Rachel H Giles, Philip Cornford, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2006
Progenitor marker CD133 mRNA is elevated in peripheral blood of cancer patients with bone metastasesNiven Mehra, Maarten Penning, Jolanda Maas, et al.
Neoplasia (New York, N.Y.)|January 15, 2010
Late release of circulating endothelial cells and endothelial progenitor cells after chemotherapy predicts response and survival in cancer patientsJeanine M Roodhart, Marlies H Langenberg, Joost S Vermaat, et al.
Pageof 13

Showing results (31-40 of 129) with videos related to

Sort By:
Pageof 13
Cytoskeleton (Hoboken, N.J.)|January 20, 2011
A role for central spindle proteins in cilia structure and functionKatherine R Smith, Esther K Kieserman, Peggy I Wang, et al.
FEBS Letters|September 11, 2007
The von Hippel-Lindau tumour suppressor interacts with microtubules through kinesin-2Martijn P Lolkema, Dorus A Mans, Cristel M Snijckers, et al.
Cilia|February 2, 2013
Reduced cilia frequencies in human renal cell carcinomas versus neighboring parenchymal tissueSander G Basten, Sven Willekers, Joost Sp Vermaat, et al.
Disease Models & Mechanisms|March 26, 2010
von Hippel-Lindau tumor suppressor mutants faithfully model pathological hypoxia-driven angiogenesis and vascular retinopathies in zebrafishEllen van Rooijen, Emile E Voest, Ive Logister, et al.
Nephron|December 23, 2014
Functional models for congenital anomalies of the kidney and urinary tractGlenn van de Hoek, Nayia Nicolaou, Rachel H Giles, et al.
European Journal of Medical Genetics|July 15, 2018
Characterization of VHL promoter variants in patients suspected of Von Hippel-Lindau diseaseSaleh Albanyan, Rachel H Giles, Enric Mocholi Gimeno, et al.
Blood|March 24, 2009
Zebrafish mutants in the von Hippel-Lindau tumor suppressor display a hypoxic response and recapitulate key aspects of Chuvash polycythemiaEllen van Rooijen, Emile E Voest, Ive Logister, et al.
European Urology Focus|October 2, 2021
Providing a Framework for Meaningful Patient Involvement in Clinical Practice Guideline Development and ImplementationJosefine Björkqvist, Rachel H Giles, Philip Cornford, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2006
Progenitor marker CD133 mRNA is elevated in peripheral blood of cancer patients with bone metastasesNiven Mehra, Maarten Penning, Jolanda Maas, et al.
Neoplasia (New York, N.Y.)|January 15, 2010
Late release of circulating endothelial cells and endothelial progenitor cells after chemotherapy predicts response and survival in cancer patientsJeanine M Roodhart, Marlies H Langenberg, Joost S Vermaat, et al.
Pageof 13